Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients

Conditions: Clear Cell Renal Cell Carcinoma Metastatic Interventions: Drug: 68Ga-NYM005 injection Sponsors: Norroy Bioscience Co., LTD Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials